Sign in
4

Changes in Ownership

Sonoma Pharmaceuticals, Inc. Filed Acc 0001683168-18-002014

Options or other derivatives

  • Chief Executive Officer acquired 67,733 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Schutz James J Chief Executive Officer 2018-07-20 Grant or award · Stock option (right to buy) +67,733 193,358 D
Loading xslF345X03/ownership.xml…